Pending FDA Clearance
Vital Metrix has developed disruptive technology for the digital healthcare arena that, PENDING FDA CLEARANCE, offers noninvasive cardiac output measurement
THE PROBLEM
Current standard measurements of cardiac output are invasive, expensive, and need to be performed in a cath lab.
Cardiac output is a measurement of the amount of blood pumped by the heart through the cardiovascular system.
Low cardiac output can indicate cardiogenic shock, heart failure, a need for mechanical support (heart pump), or other conditions.
High cardiac output can indicate sepsis or a widespread systemic infection, which causes about 1 in 5 deaths globally.
Early detection of high or low cardiac output is often needed for timely, life-saving intervention.
THE SOLUTION
Vital Metrix will offer non-invasive, periodic or continuous, cost effective cardiac output measurement in hospitals and eventually physician’s offices, other outpatient settings, and home care.
1. Our patented algorithm works with off-the-shelf sensors (Pending FDA Clearance)
2. The procedure is completely non-invasive
3. The cost is significantly lower
POTENTIAL HEART FAILURE MARKET
6.5 Million
AMERICANS SUFFER FROM CONGESTIVE HEART FAILURE
500,000
NEW PATIENTS ARE DIAGNOSED EVERY YEAR
50%
OF PATIENTS DIE WITHIN 5 YEARS AFTER DIAGNOSIS
Our Patented Algorithm
NINE ISSUED PATENTS • SEVEN PENDING PATENTS
